Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.84246 | 64 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.94189 | 65 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.77321 | 63 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.27914 | 54 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.79115 | 64 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.8322 | 63 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.05787 | 66 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.81373 | 64 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.81014 | 64 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.82704 | 64 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.22965 | 69 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.85497 | 65 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.82925 | 64 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.82813 | 64 |